에 대한 최신 뉴스 Napatech (OTC:NPTSF) 주식

Napatech AS is a tech company. It enhances open and standard virtualized servers to boost innovation and release valuable computing resources that improve services and increase revenue. The Group manufactures and sells network adapters to end-users and through third-party channel partners. It derives maximum of its revenue from the Americas.

Napatech AS

Everus Construction Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECG#NYSE">ECG</a>) affirms FY2025 sales outlook from $3.00 billion-$3.10 billion to $3.00 billion-$3.10 billion vs $3.05 billion estimate.

News

Guidance

Everus Construction Group Affirms FY2025 Sales Guidance of $3.00B-$3.10B vs $3.05B Est

Alcon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALC#NYSE">ALC</a>) lowers FY2025 Adj EPS guidance from $3.15-$3.25 to $3.05-$3.15 vs $3.20 analyst estimate. Raises FY2025 sales outlook from $10.20 billion-$10.40 billion to $10.40 billion-$10.50 billion vs $10.42 billion estimate.

Alcon Lowers FY2025 Adj EPS Guidance from $3.15-$3.25 to $3.05-$3.15 vs $3.20 Est; Raises FY2025 Sales Guidance from $10.20B-$10.40B to $10.40B-$10.50B vs $10.42B Est

Karman Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRMN#NYSE">KRMN</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.01 by 400 percent. This is a 66.67 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $100.12 million which beat the analyst consensus estimate of $95.18 million by 5.19 percent. This is a 20.62 percent increase over sales of $83.01 million the same period last year.

Earnings

Earnings Beats

KRMN

Karman Holdings Q1 Adj. EPS $0.05 Beats $0.01 Estimate, Sales $100.12M Beat $95.18M Estimate

Buybacks

ELMD

Electromed Approved $5M Repurchase Authorization

Everus Construction Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECG#NYSE">ECG</a>) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.43 by 67.44 percent. This is a 30.91 percent increase over earnings of $0.55 per share from the same period last year. The company reported quarterly sales of $826.63 million which beat the analyst consensus estimate of $676.35 million by 22.22 percent. This is a 32.11 percent increase over sales of $625.69 million the same period last year.

Everus Construction Group Q1 EPS $0.72 Beats $0.43 Estimate, Sales $826.63M Beat $676.35M Estimate

CI&amp;T (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CINT#NYSE">CINT</a>) Q2 Revenue expected to be more than $115.50M vs $111.71M Est

CINT

CI&T Q2  Revenue expected to be more than $115.50M vs $111.71M Est

California Gov. Gavin Newsom is pushing back against what he calls a flood of misinformation targeting his state, launching a new website to directly counter false claims about California's economy, crime, and public safety.&nbsp;
In a <a href="https://x.com/GavinNewsom/status/1920273143492718791">post on X</a>, Newsom said, "We're the <a href="https://www.benzinga.com/25/04/45002621/california-overtakes-japan-to-become-worlds-fourth-largest-economy-progress-threatened-by-reckless-tariff-policies-warns-governor-newsom">4th largest economy in the world</a>. Our population continues to grow. We're done letting the trolls define the Golden State. We're going on the offense and fighting back — with facts."
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">The Facts Behind the Firestorm</h2>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">NEW: We just launched a new site to call out the misinformation machine that consistently spews lies about CA. We're the 4th largest economy in the world. Our population continues to grow. And we're done letting the trolls define the Golden State. We're going on the offense… <a href="https://t.co/1gDAXq01zs">pic.twitter.com/1gDAXq01zs</a>
&mdash; Gavin Newsom (@GavinNewsom) <a href="https://twitter.com/GavinNewsom/status/1920273143492718791?ref_src=twsrc%5Etfw">May 8, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Among the issues <a href="http://californiafacts.com/">Californiafacts.com</a> addresses is misinformation about <a href="https://www.benzinga.com/news/25/01/43095813/california-wildfires-to-cost-275-billion-critics-slam-gov-newsoms-101m-firefighting-cuts-amid-record-rainfall-in-2023">California's wildfire response</a>, water supply, and energy management. For instance, a popular <a href="https://x.com/libsoftiktok/status/1877018339983167771">post</a> from Libs of TikTok claimed, "There's no water coming out of the fire hydrants because the city didn't fill the reservoirs but at least the fire chief is a woman and gay!"&nbsp;
In <a href="https://californiafacts.com/no-california-did-not-run-out-of-water-while-fighting-the-la-wildfires/">response</a>, the site clarifies that Southern California's reservoirs were at record levels during the recent fire season, including 3.8 million acre-feet of stored water, which can supply 40 million people for a year. While some hydrants temporarily ran dry due to extreme conditions, the broader water system was never at risk of running out, and an independent investigation is underway to understand the localized pressure issues, the website states.
The site also pushes back against other wildfire-related claims, including allegations that California failed to &#8220;rake the forest&#8221; or that firefighting budgets were slashed before the recent blazes.&nbsp;
Trending: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a>
According to the site, California has invested $2 billion in forest management, along with an annual $200 million budget for ongoing prevention efforts. Additionally, the number of CalFIRE personnel has nearly doubled since 2019.
<h2 class="wp-block-heading">Setting the Record Straight</h2>
The site covers a wide range of other topics, including economic growth, crime rates, and energy policy:
<ul class="wp-block-list">
<li>Business and Economy: California is the largest manufacturing state, contributing 14.5% of U.S. manufacturing GDP. It also ranks No. 1 for new business starts and access to venture capital funding.</li>
<li>Population Trends: Despite claims of mass exodus, California's population grew by 108,000 in 2024, reaching 39.5 million.</li>
<li>Crime and Public Safety: Newsom has more than doubled the California National Guard on the southern border to combat fentanyl trafficking, and preliminary data shows an 8.3% decline in violent crime in California cities in 2024.</li>
<li>Energy and Clean Power: Despite claims that clean energy can't meet the state's power demands, the site notes that clean energy supply met or exceeded demand for the equivalent of 51 days in 2024.</li>
</ul>
With this new website, Newsom's message is that California is the world's fourth-largest economy, and the state is prepared to challenge the narratives that critics use to define it.
Read Next:
<ul class="wp-block-list">
<li>Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—<a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share.</a></li>
<li><a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market">Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.</a></li>
</ul>
Image: Shutterstock

'Fighting Back With Facts'—CA Gov. Newsom Is Done With The Trolls, Launches Website To Shut Down Lies About World's 4th Largest Economy

Alcon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALC#NYSE">ALC</a>) reported quarterly earnings of $0.73 per share which missed the analyst consensus estimate of $0.75 by 2.67 percent. This is a 6.41 percent decrease over earnings of $0.78 per share from the same period last year. The company reported quarterly sales of $2.45 billion which missed the analyst consensus estimate of $2.51 billion by 2.46 percent. This is a 0.29 percent increase over sales of $2.44 billion the same period last year.

Earnings Misses

Alcon Q1 Adj. EPS $0.73 Misses $0.75 Estimate, Sales $2.45B Miss $2.51B Estimate

SELLAS Life Sciences Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLS#NASDAQ">SLS</a>) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 30 percent. This is a 66.67 percent increase over losses of $(0.21) per share from the same period last year.

SELLAS Life Sciences Gr Q1 EPS $(0.07) Beats $(0.10) Estimate

Offerings

LOAR

Loar Launches Secondary Public Offering Of 9M Shares

DiaMedica Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMAC#NASDAQ">DMAC</a>) reported quarterly losses of $(0.18) per share which met the analyst consensus estimate. This is a 28.57 percent decrease over losses of $(0.14) per share from the same period last year.

DMAC

DiaMedica Therapeutics Q1 EPS $(0.18), Inline

64% (9/14) complete response rate with AlloNK + rituximab in heavily pretreated patients that were naïve to prior CAR-T cell therapy, in line with approved auto-CAR-T therapies in aggressive B-NHL
Median duration of response for AlloNK + rituximab not yet reached and is at least 19.4 months, in line with approved auto-CAR-T therapies in aggressive B-NHL
AlloNK's activity and well-tolerated safety profile in aggressive B-NHL patients support the potential to deliver deep B-cell depletion in a refractory autoimmune population in outpatient community settings
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTV#NASDAQ">ARTV</a>), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced new longer-term Phase 1/2 data demonstrating durable responses for AlloNK&#xAE; (also known as AB-101) in combination with rituximab (RTX) in patients with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL) at the American Society of Gene &amp; Cell Therapy (ASGCT) 28th annual meeting.

Biotech

General

ARTV

Artiva Biotherapeutics Announces Longer-Term Phase 1/2 Data Demonstrating Prolonged Durability For AlloNK In Combination With Rituximab In Patients With B-cell-Non-Hodgkin Lymphoma At The ASGCT 28th Annual Meeting

Arteris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIP#NASDAQ">AIP</a>) widens FY2025 sales outlook from $66.00 million-$70.00 million to $65.00 million-$71.00 million vs $68.40 million estimate.

Arteris Widens FY2025 Sales Guidance from $66.00M-$70.00M to $65.00M-$71.00M vs $68.40M Est

CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) has outperformed the market over the past 10 years by 7.21% on an annualized basis producing an average annual return of 17.87%. Currently, CACI International has a market capitalization of $10.16 billion. 
Buying $100 In CACI: If an investor had bought $100 of CACI stock 10 years ago, it would be worth $518.27 today based on a price of $462.04 for CACI at the time of writing.
<h3>CACI International's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747168214_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CACI

$100 Invested In CACI International 10 Years Ago Would Be Worth This Much Today

Arteris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIP#NASDAQ">AIP</a>) sees Q2 sales of $16.100 million-$16.500 million vs $15.90 million analyst estimate.

Arteris Sees Q2 Sales $16.100M-$16.500M vs $15.90M Est

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 35.12% at $0.96</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 25.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 17.28% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 10.57% at $0.15</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 9.70% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 7.14% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed up 5.89% at $0.87</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 5.26% at $1.60</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed up 5.08% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed up 4.65% at $4.50</li>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed up 4.35% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 3.78% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 3.74% at $1.15</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 3.51% at $59.00</li>
<li><a href="https://www.benzinga.com/quote/ESE">ESCO Technologies</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) shares closed up 3.25% at $185.41</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 13.00% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 12.12% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 10.83% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 10.70% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 8.09% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed down 4.62% at $0.06</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

Movers

BBRRF

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CLSH

CNTMF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CVSI

CWBHF

CXXIF

FFNTF

GBHPF

GNLN

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

OILFF

RMHB

TCNNF

TGIFF

XXII

Cannabis Stock Gainers And Losers From May 13, 2025

KinderCare Learning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLC#NYSE">KLC</a>) affirms FY2025 Adj EPS guidance from $0.75-$0.85 to $0.75-$0.85 vs $0.79 analyst estimate. Affirms FY2025 sales outlook from $2.75 billion-$2.85 billion to $2.75 billion-$2.85 billion vs $2.81 billion estimate.

KinderCare Learning Affirms FY2025 Adj EPS Guidance of $0.75-$0.85 vs $0.79 Est; Affirms FY2025 Sales Guidance of $2.75B-$2.85B vs $2.81B Est

Arteris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIP#NASDAQ">AIP</a>) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is a 40 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $16.53 million which beat the analyst consensus estimate of $15.90 million by 3.97 percent. This is a 27.69 percent increase over sales of $12.95 million the same period last year.

Arteris Q1 Adj. EPS $(0.09), Inline, Sales $16.53M Beat $15.90M Estimate

Exchangeable for Class A Common Stock of Aurora Innovation, Inc.
Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) today announced that it intends to offer, subject to market conditions and other factors, $1.0 billion principal amount of Exchangeable Senior Notes due 2028 (the "notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Uber also intends to grant the initial purchaser of the notes an option to purchase up to an additional $150 million principal amount of the notes.
The notes will be exchangeable into cash, or, subject to the satisfaction of certain share delivery conditions, units of reference property, or a combination of cash and units of reference property, at Uber's election. Initially, each unit of reference property will be comprised of one share of Class A common stock, par value $0.00001 per share, of Aurora Innovation, Inc. ("Aurora common stock"). The interest rate, initial exchange rate, repurchase rights, redemption rights and other terms of the notes will be determined at the time of pricing of the offering.
The notes will be Uber's senior obligations and will be secured by first-priority liens on certain pledged reference property held by Uber's indirect wholly owned subsidiary, Neben Holdings, LLC ("Neben") (which pledged reference property will initially consist of the maximum number of shares of Aurora common stock deliverable upon exchange of the notes). The notes will be guaranteed by Neben on a limited recourse basis to the extent of the pledged reference property.

UBER

Uber Announces Proposed Private Placement Of $1B Of Exchangeable Senior Senior Notes Due 2028

KinderCare Learning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLC#NYSE">KLC</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.17 by 35.29 percent. The company reported quarterly sales of $668.24 million which missed the analyst consensus estimate of $680.94 million by 1.86 percent.

Comments

Napatech

뉴스

에 대한 최신 뉴스 Napatech (OTC:NPTSF) 주식

뉴스

파트너 / 기고자

벤징가 글로벌